Skip to content

Continuous positive airway pressure in premature infants with respiratory distress syndrome

Comparison of bubble CPAP standard CPAP for treatment of respiratory distress syndrome in premature infants

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014032716870N2
Enrollment
40
Registered
2014-04-19
Start date
2012-05-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory distress syndrome of preterm neonates. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Group Intervention: The intervention group infants The use of continuous positive airway pressure ventilation Bubble Construction of the New Zealand company Fisher Vpykl The total dura
Treatment - Devices
Group Intervention: The intervention group infants The use of continuous positive airway pressure ventilation Bubble Construction of the New Zealand company Fisher Vpykl The total duration of the s
Control group: The control group infants using: Continuous positive airway pressure ventilation standard Model Bear750psv Made in America During the whole period of study

Sponsors

Shahid Sadoughi University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infants with a gestational age of 28 to 34 weeks with respiratory distress syndrome Exclusion criteria: Life-threatening congenital malformations Severe asphyxia Sepsis hematocrit less than 35 Intracranial hemorrhage and intraventricular hemorrhage grade three or four

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of mechanical ventilation. Timepoint: daily. Method of measurement: Registration time day.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadijeh Nasiriani

Shahid Sadoughi University of Medical Sciences

nasiriani@gmail.com; nasiriani@ssu.ac.ir+98 35 1824 1755

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026